Châtenay-Malabry, France

Philippe Riviere

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Riviere. Retrieved from https://idiyas.com/inventor/philippe-riviere-w6oczwzq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Philippe Riviere: Innovator in Oral Composition Technology

Introduction

Philippe Riviere is a notable inventor based in Châtenay-Malabry, France. He has made significant contributions to the field of oral compositions, particularly through his innovative work involving quinolones. His expertise and dedication to research have led to the development of valuable patents that enhance the pharmaceutical industry.

Latest Patents

Philippe Riviere holds a patent titled "Process for the preparation of oral compositions containing quinolones." This patent represents a crucial advancement in the formulation of oral medications, showcasing his commitment to improving healthcare solutions.

Career Highlights

Riviere is associated with Rhone-Poulenc Rorer S.A., a prominent company in the pharmaceutical sector. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research and development.

Collaborations

One of his notable coworkers is Gabriel Gousset. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Philippe Riviere's contributions to the development of oral compositions highlight his role as an influential inventor in the pharmaceutical industry. His patent work and collaborations continue to impact healthcare positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…